ArticleMolecular neurobiology2026
Cuproptosis Inhibition by C-Phycocyanin Confers Neuroprotection against Copper-Induced Mitochondrial Damage and Cognitive Impairment.
Article in Molecular neurobiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Heavy Metal-Induced Retinal Injury in Zebrafish (Toxics · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
Copper (Cu) is an essential trace element, but its dyshomeostasis has been increasingly linked to neurotoxicity and neurodegenerative diseases. The specific contribution of cuproptosis, a novel copper-dependent regulated cell death pathway, to neuronal damage remains poorly defined. This study evaluated the neuroprotective potential of C-phycocyanin (C-PC), a natural compound derived from Spirulina, against Cu-induced neurotoxicity, with a focus on cuproptosis. In vitro, C-PC treatment markedly attenuated Cu-induced cell death in mouse neuronal cells. It restored mitochondrial membrane potential, ameliorated oxidative stress by reducing malondialdehyde (MDA) and elevating adenosine triphosphate (ATP) levels, and restored key cuproptosis markers, including FDX1 and lipoylated DLAT. In Cu-exposed mice, oral administration of C-PC ameliorated cognitive deficits, as assessed by the Morris water maze test, and reduced neuronal loss in the hippocampus. Biochemical analysis of brain tissue further confirmed that C-PC mitigated oxidative damage and suppressed the expression of cuproptosis-related proteins. These results indicate that C-PC is a potent inhibitor of cuproptosis, exerting its effects primarily by preserving mitochondrial integrity and reducing proteotoxic stress. Given its biocompatibility and natural origin, C-PC represents a promising therapeutic candidate for countering Cu-induced neurotoxicity.
Indexed as
Identifiers
41922617What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.